Clinical Trials
2,548 trialsEvolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)
UNICANCER
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
Mayo Clinic
TICP
Hospices Civils de Lyon
PASSAT
AstraZeneca
OSIREAL
AstraZeneca
LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B
Massachusetts General Hospital
MK-3475-U01
Merck Sharp & Dohme LLC
ICARE-LCS
VA Office of Research and Development
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Hoffmann-La Roche
Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China
National Institutes of Health Clinical Center (CC)
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
National Institutes of Health Clinical Center (CC)
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
National Institutes of Health Clinical Center (CC)
Bio-lung
University Hospital, Lille
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
National Institutes of Health Clinical Center (CC)
SCOOT
University of Oxford
CREATE
AstraZeneca
RACE-2L
AstraZeneca
NAUTIC
AstraZeneca
LUNG-ROLL
AstraZeneca
CHOICE
AstraZeneca
A Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese Adults With ALK-positive a/mNSCLC
Pfizer
IMOTION
Nanfang Hospital, Southern Medical University
POPPY
University of Sydney
DESCENT-1
A2 Biotherapeutics Inc.
A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)
Ono Pharmaceutical Co., Ltd.
Pan HER2
AstraZeneca
Repotrectinib Post-Marketing Surveillance in Korean Patients With ROS1-Positive Non-Small Cell Lung Cancer (NSCLC) or Solid Tumors Harboring a Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion
Bristol-Myers Squibb
VENTURE
University of Sydney
A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.
Pfizer
FOREFRONT
AstraZeneca
Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
AstraZeneca
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
Washington University School of Medicine
Tumor-informed MRD for Non-small Cell Lung Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
MYLUNG
US Oncology Research
MYLUNG
US Oncology Research
OvAR-Y
Washington University School of Medicine
ALCG-01
Gazi University
Preoperative Decision-Making in Patients With Pulmonary Nodules Suspected of Lung Cancer
Sichuan Cancer Hospital and Research Institute
ECHO
AstraZeneca
Piloting a Virtual Navigation (VN) System for Bronchoscopic Lung Nodule Sampling
Penn State University
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
Detection of Cancer in Breath Samples by Trained Detection Dogs
SpotitEarly
SPARC
University of Utah
ROSE
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
ASCENT
University College, London
SECURE
AstraZeneca
Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC
National Cancer Centre, Singapore
National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute (NCI)
CEMI-LUNG
Regeneron Pharmaceuticals